GlobeNewswire

First to demonstrate clinical benefit in patients with chronic inducible urticaria (CIndU) in large, randomized, placebo-controlled …

TORONTO, Oct. 25, 2024 (GLOBE NEWSWIRE) — (TSX: XLVE) Mulvihill Capital Management Inc. (the “Manager”), …

WARREN, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings …

NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor …

CARLSBAD, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) — CarnoSyn® Brands and parent company Natural Alternatives …

SAN DIEGO, Oct. 23, 2024 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP, …

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES …

LOWELL, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) — Enterprise Bancorp, Inc. (NASDAQ: EBTC), parent of …

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights …

LA JOLLA, CA, Oct. 21, 2024 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI …